2012, COVID-19 Vaccine, FDA and Licensing - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

COVID-19 Vaccine

FDA

Licensing

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

APRIL 7, 2023

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government substantially de-risking the vaccine development process.

COVID-19 Vaccine

COVID-19 Vaccine COVID-19 Governance Public Health

A Texas Mess

Drug & Device Law

JANUARY 4, 2024

2012), we hailed it as the best decision of 2012. So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic.

COVID-19 Vaccine

COVID-19 Vaccine COVID-19 FDA Public Health

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

A Texas Mess

Stay Connected